Cargando…

Collateral benefits arising from mass administration of azithromycin in the control of active trachoma in resource limited settings

INTRODUCTION: The benefits of the use of antibiotics in the mass treatment for active trachoma and other diseases have been documented, but the secondary effects arising from such a programme have not been fully elucidated. The purpose of this study was to investigate the potential secondary benefit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kigen, Gabriel, Rotich, Joseph, Karimurio, Jefitha, Rono, Hillary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The African Field Epidemiology Network 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382070/ https://www.ncbi.nlm.nih.gov/pubmed/25852799 http://dx.doi.org/10.11604/pamj.2014.19.256.3548

Ejemplares similares

Knowledge, practices and perceptions of trachoma and its control among communities of Narok County, Kenya
por: Njomo, Doris W., et al.
Publicado: (2016)

Use of validated community-based trachoma trichiasis (TT) case finders to measure the total backlog and detect when elimination threshold is achieved: a TT methodology paper
por: Karimurio, Jefitha, et al.
Publicado: (2017)

Mass treatment for trachoma: how does it all work?
por: Rono, Hillary K
Publicado: (2013)

Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021)

Effectiveness of azithromycin mass drug administration on trachoma: a systematic review
por: Xiong, Tao, et al.
Publicado: (2021)

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
por: Harrison, Mark Andrew, et al.
Publicado: (2019)

Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings
por: Kamuren, Zipporah, et al.
Publicado: (2018)

Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx
por: Gladstone, Rebecca A., et al.
Publicado: (2021)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

A study of the medicinal plants used by the Marakwet Community in Kenya
por: Kipkore, Wilson, et al.
Publicado: (2014)

Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
por: Schachterle, Stephen E., et al.
Publicado: (2014)

Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
por: Marks, M, et al.
Publicado: (2016)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma
por: Ho, Derek K-H., et al.
Publicado: (2015)

Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Prevalence of Trachoma in Car-Nicobar Island, India after Three Annual Rounds of Mass Drug Administration with Azithromycin
por: Malhotra, Sumit, et al.
Publicado: (2016)

Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma
por: Marks, Michael, et al.
Publicado: (2016)

Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia
por: Astale, Tigist, et al.
Publicado: (2018)

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children
por: Pickering, Harry, et al.
Publicado: (2022)

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws
por: Marks, Michael, et al.
Publicado: (2015)

Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities
por: Wilson, Nana, et al.
Publicado: (2018)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control
por: Burr, Sarah E, et al.
Publicado: (2014)

Correction: Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma
Publicado: (2018)

Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia
por: Ebert, Caleb D., et al.
Publicado: (2019)

To eliminate trachoma: Azithromycin mass drug administration coverage and associated factors among adults in Goro district, Southeast Ethiopia
por: Feyisa, Tadele, et al.
Publicado: (2022)

Changes in trachoma indicators in Kiribati with two rounds of azithromycin mass drug administration, measured in serial population-based surveys
por: Goodhew, E. Brook, et al.
Publicado: (2023)

Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review
por: Kigen, Gabriel, et al.
Publicado: (2017)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

A Cross-Sectional Study of ‘Yaws’ in Districts of Ghana Which Have Previously Undertaken Azithromycin Mass Drug Administration for Trachoma Control
por: Ghinai, Rosanna, et al.
Publicado: (2015)

Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control
por: Bojang, Ebrima, et al.
Publicado: (2017)

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014)

Benefits and Barriers to Increasing Regional Anesthesia in Resource-Limited Settings
por: Dohlman, Lena Ebba, et al.
Publicado: (2020)

Eliminating Trachoma in Areas with Limited Disease
por: Gaynor, Bruce D., et al.
Publicado: (2003)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

Prevalence of Trachoma at Sub-District Level in Ethiopia: Determining When to Stop Mass Azithromycin Distribution
por: King, Jonathan D., et al.
Publicado: (2014)

Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia
por: Burr, Sarah E., et al.
Publicado: (2013)

Primary bladder neck obstruction (PBNO) in children in a resource-limited setting
por: Mugalo, E. Lumadede, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9rtc63fm2e1hbs696bdlihse41